12:00 AM
 | 
Aug 15, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

RSV-F vaccine: Completed Phase I enrollment

Novavax completed enrollment of about 150 healthy volunteers ages 18-49 in a double-blind, placebo-controlled, dose-escalation, U.S. Phase I trial evaluating 2 doses of intramuscular RSV-F vaccine given about 30 days apart....

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >